Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ATRI's Cash to Debt is ranked higher than
84% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. ATRI: No Debt )
ATRI' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: No Debt

Equity to Asset 0.87
ATRI's Equity to Asset is ranked higher than
93% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. ATRI: 0.87 )
ATRI' s 10-Year Equity to Asset Range
Min: 0.61   Max: 0.88
Current: 0.87

0.61
0.88
Interest Coverage No Debt
ATRI's Interest Coverage is ranked higher than
96% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.61 vs. ATRI: No Debt )
ATRI' s 10-Year Interest Coverage Range
Min: 4   Max: 9999.99
Current: No Debt

4
9999.99
F-Score: 8
Z-Score: 18.11
M-Score: -2.99
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 28.75
ATRI's Operating margin (%) is ranked higher than
96% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.44 vs. ATRI: 28.75 )
ATRI' s 10-Year Operating margin (%) Range
Min: 1.65   Max: 32.43
Current: 28.75

1.65
32.43
Net-margin (%) 20.14
ATRI's Net-margin (%) is ranked higher than
93% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.65 vs. ATRI: 20.14 )
ATRI' s 10-Year Net-margin (%) Range
Min: 4.35   Max: 56.77
Current: 20.14

4.35
56.77
ROE (%) 17.84
ATRI's ROE (%) is ranked higher than
92% of the 283 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. ATRI: 17.84 )
ATRI' s 10-Year ROE (%) Range
Min: 4.45   Max: 34.4
Current: 17.84

4.45
34.4
ROA (%) 15.45
ATRI's ROA (%) is ranked higher than
96% of the 290 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.24 vs. ATRI: 15.45 )
ATRI' s 10-Year ROA (%) Range
Min: 3.56   Max: 28.24
Current: 15.45

3.56
28.24
ROC (Joel Greenblatt) (%) 41.08
ATRI's ROC (Joel Greenblatt) (%) is ranked higher than
89% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.38 vs. ATRI: 41.08 )
ATRI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 3.33   Max: 44.8
Current: 41.08

3.33
44.8
Revenue Growth (%) 7.00
ATRI's Revenue Growth (%) is ranked higher than
75% of the 248 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. ATRI: 7.00 )
ATRI' s 10-Year Revenue Growth (%) Range
Min: -24.9   Max: 56.2
Current: 7

-24.9
56.2
EBITDA Growth (%) 7.20
ATRI's EBITDA Growth (%) is ranked higher than
75% of the 210 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.40 vs. ATRI: 7.20 )
ATRI' s 10-Year EBITDA Growth (%) Range
Min: -40.1   Max: 131.8
Current: 7.2

-40.1
131.8
EPS Growth (%) 8.50
ATRI's EPS Growth (%) is ranked higher than
78% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. ATRI: 8.50 )
ATRI' s 10-Year EPS Growth (%) Range
Min: 8.5   Max: 59.9
Current: 8.5

8.5
59.9
» ATRI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

ATRI Guru Trades in Q1 2013

Chuck Royce 244,957 sh (+8.59%)
Jim Simons 6,500 sh (+4.84%)
» More
Q2 2013

ATRI Guru Trades in Q2 2013

Joel Greenblatt 1,002 sh (New)
Jim Simons 8,600 sh (+32.31%)
Chuck Royce 256,993 sh (+4.91%)
» More
Q3 2013

ATRI Guru Trades in Q3 2013

Joel Greenblatt 2,763 sh (+175.75%)
Jim Simons 10,100 sh (+17.44%)
Chuck Royce 258,035 sh (+0.41%)
» More
Q4 2013

ATRI Guru Trades in Q4 2013

Jim Simons 13,500 sh (+33.66%)
Joel Greenblatt 2,936 sh (+6.26%)
Chuck Royce 243,432 sh (-5.66%)
» More
» Details

Insider Trades

Latest Guru Trades with ATRI

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-09-30 Add 175.75%0.01%$218.65 - $260.43 $ 291.4620%2763
Joel Greenblatt 2013-06-30 New Buy0.01%$186.37 - $221.96 $ 291.4641%1002
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Atrion Corporation

Billionaires Hold Three Undervalued, Predictable Stocks with Yield
Up from a week ago, 89 U.S. companies and more than 100 other companies worldwide are currently listed as undervalued and predictable. When GuruFocus applies discounted cash flow and discounted earnings to top ranked predictable companies, and calculates their intrinsic values, these companies appear to be undervalued. Read more about the assumptions and methodology used here. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 23.20
ATRI's P/E(ttm) is ranked higher than
63% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.10 vs. ATRI: 23.20 )
ATRI' s 10-Year P/E(ttm) Range
Min: 8.12   Max: 24.85
Current: 23.2

8.12
24.85
P/B 4.00
ATRI's P/B is ranked lower than
52% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. ATRI: 4.00 )
ATRI' s 10-Year P/B Range
Min: 1.06   Max: 4.16
Current: 4

1.06
4.16
P/S 4.45
ATRI's P/S is ranked lower than
70% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.60 vs. ATRI: 4.45 )
ATRI' s 10-Year P/S Range
Min: 0.8   Max: 4.92
Current: 4.45

0.8
4.92
PFCF 21.90
ATRI's PFCF is ranked higher than
73% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.00 vs. ATRI: 21.90 )
ATRI' s 10-Year PFCF Range
Min: 6.69   Max: 429.32
Current: 21.9

6.69
429.32
EV-to-EBIT 14.50
ATRI's EV-to-EBIT is ranked higher than
76% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.32 vs. ATRI: 14.50 )
ATRI' s 10-Year EV-to-EBIT Range
Min: 4.6   Max: 15.9
Current: 14.5

4.6
15.9
PEG 2.70
ATRI's PEG is ranked higher than
58% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.13 vs. ATRI: 2.70 )
ATRI' s 10-Year PEG Range
Min: 0.2   Max: 6.3
Current: 2.7

0.2
6.3
Shiller P/E 26.10
ATRI's Shiller P/E is ranked higher than
61% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.28 vs. ATRI: 26.10 )
ATRI' s 10-Year Shiller P/E Range
Min: 11.46   Max: 29.95
Current: 26.1

11.46
29.95

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.85
ATRI's Dividend Yield is ranked lower than
67% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. ATRI: 0.85 )
ATRI' s 10-Year Dividend Yield Range
Min: 0.25   Max: 1.74
Current: 0.85

0.25
1.74
Dividend Payout 0.18
ATRI's Dividend Payout is ranked higher than
86% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.33 vs. ATRI: 0.18 )
ATRI' s 10-Year Dividend Payout Range
Min: 0.09   Max: 0.54
Current: 0.18

0.09
0.54
Dividend growth (3y) 15.40
ATRI's Dividend growth (3y) is ranked higher than
87% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.00 vs. ATRI: 15.40 )
ATRI' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 45.5
Current: 15.4

0
45.5
Yield on cost (5-Year) 1.90
ATRI's Yield on cost (5-Year) is ranked higher than
57% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. ATRI: 1.90 )
ATRI' s 10-Year Yield on cost (5-Year) Range
Min: 0.53   Max: 3.67
Current: 1.9

0.53
3.67
Share Buyback Rate 0.20
ATRI's Share Buyback Rate is ranked higher than
86% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.70 vs. ATRI: 0.20 )
ATRI' s 10-Year Share Buyback Rate Range
Min: 12.9   Max: -2.4
Current: 0.2

Valuation & Return

vs
industry
vs
history
Price/Net Cash 24.30
ATRI's Price/Net Cash is ranked lower than
65% of the 68 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.30 vs. ATRI: 24.30 )
ATRI' s 10-Year Price/Net Cash Range
Min: 2.1   Max: 108.11
Current: 24.3

2.1
108.11
Price/Net Current Asset Value 12.20
ATRI's Price/Net Current Asset Value is ranked higher than
53% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.00 vs. ATRI: 12.20 )
ATRI' s 10-Year Price/Net Current Asset Value Range
Min: 1.76   Max: 42.81
Current: 12.2

1.76
42.81
Price/Tangible Book 4.30
ATRI's Price/Tangible Book is ranked higher than
57% of the 232 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. ATRI: 4.30 )
ATRI' s 10-Year Price/Tangible Book Range
Min: 0.81   Max: 4.35
Current: 4.3

0.81
4.35
Price/DCF (Projected) 1.60
ATRI's Price/DCF (Projected) is ranked higher than
54% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. ATRI: 1.60 )
ATRI' s 10-Year Price/DCF (Projected) Range
Min: 0.84   Max: 13.4
Current: 1.6

0.84
13.4
Price/Median PS Value 1.90
ATRI's Price/Median PS Value is ranked lower than
68% of the 268 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. ATRI: 1.90 )
ATRI' s 10-Year Price/Median PS Value Range
Min: 0.2   Max: 1.91
Current: 1.9

0.2
1.91
Price/Peter Lynch Fair Value 2.80
ATRI's Price/Peter Lynch Fair Value is ranked lower than
68% of the 76 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. ATRI: 2.80 )
ATRI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.41   Max: 2.86
Current: 2.8

0.41
2.86
Price/Graham Number 2.00
ATRI's Price/Graham Number is ranked higher than
65% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. ATRI: 2.00 )
ATRI' s 10-Year Price/Graham Number Range
Min: 0.34   Max: 2.49
Current: 2

0.34
2.49
Earnings Yield (Greenblatt) 6.90
ATRI's Earnings Yield (Greenblatt) is ranked higher than
76% of the 226 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. ATRI: 6.90 )
ATRI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6.3   Max: 21.6
Current: 6.9

6.3
21.6
Forward Rate of Return (Yacktman) 11.21
ATRI's Forward Rate of Return (Yacktman) is ranked higher than
85% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. ATRI: 11.21 )
ATRI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -18.1   Max: 75.6
Current: 11.21

-18.1
75.6

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Atrion Corporation is incorporated in Delaware. The Company and its subsidiaries develop and manufacture products, mainly for medical applications. Its medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include proprietary valves that promote infection control and needle safety. It has developed a variety of luer syringe check valves and one-way valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, catheter and other applications. It also make tubing clamps in a variety of materials and colors that are compatible with various grades of tubing and sterilization processes, and produce specialized intravenous sets for use in numerous applications including anesthesia and oncology. Its cardiovascular products include MPS2 Myocardial Protection System, or MPS2, a proprietary technology that delivers essential fluids and medications to the heart during open-heart surgery. The MPS2 integrates key functions relating to the delivery of solutions to the heart, such as varying the rate and ratio of oxygenated blood, crystalloid, potassium and other additives, and controlling temperature, pressure and other variables to allow simpler, more flexible management of this process, indicating improved patient outcomes. The MPS2 is the only device used in open-heart surgery that allows for the mixing of drugs into the bloodstream without diluting the blood. The MPS2 employs advanced pump, temperature control and microprocessor technologies and includes a line of disposable products. It also develop and manufacture other cardiovascular products such as cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels in minimally invasive surgical procedures; inflation devices for balloon catheter dilation, stent deployment and fluid dispensing; as well as products used in heart bypass surgery to make a precision opening in the heart for attachment of the bypass vessels. The Company is a manufacturer of contact lens disinfection cases. It also manufacture a proprietary line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Nasolacrimal duct obstruction can cause a condition called epiphora, or chronic tearing. People affected by this condition experience excessive and uncontrollable tearing and often encounter infection as a result of nasolacrimal blockage. In addition, it manufactures and sells a line of products designed for safe needle and scalpel blade containment. It is also the manufacturer of inflation systems and valves used in marine and aviation safety products. It manufactures inflation systems and valves for products such as life vests, life rafts, inflatable boats, survival equipment, and other inflatable structures. It also produce one-way and two-way pressure relief valves for use on electronics cases, munitions cases,

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide